Clinical trial
Effect of Growth Hormone Receptor Antagonism and Somatostatin Analog Administration on Quality of Life
NCT01732406 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Growth Hormone Receptor Antagonism and Somatostatin Analog Administration on Quality of Life
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- December 19, 2016
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.